CClinicalTrials.gg
CompletedNCT01537211CLEGUpdated Sep 6, 2019Results posted

Functional Outcomes in Dysvascular Transfemoral Amputees

An interventional study of C leg compared to subject's mechanical leg (Otto Bock) and C leg compared to subject's mechanical leg (Otto Bock) in Transfemoral Amputation and Unilateral Traumatic Amputation of Leg at or Above Knee, sponsored by Shirley Ryan AbilityLab. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-09-06.

Sponsored by Shirley Ryan AbilityLab · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

In older adults, poor circulation in the lower extremities leads to serious health complications including limb loss. In addition, individuals with dysvascular disease also suffer from other co-morbidities like diabetes, coronary and cerebrovascular disease. An individual with a transfemoral (TF) amputation is usually fitted with a prosthetic limb to assist with function, including a prosthetic knee and a prosthetic foot. Currently, dysvascular amputees are given a prosthetic knee based on the basic expectation that they will be functionally stable. This consideration does not address higher levels of function like walking at multiple speeds and over uneven ground. Also, dysvascular amputees are not able to counteract their co-morbidities with a more active lifestyle. Walking is less energy efficient; their traditional prostheses may cause early onset of fatigue and induce a fear of falling. Newer microprocessor knees enable patients with transfemoral amputations to walk on different surfaces and at multiple cadences through better control in swing and stance phases of gait. The impact of the functional differences in the prostheses is not clear and requires additional investigation to clarify the choice of the most appropriate functional prosthesis. The purpose of this study is to compare the functional outcomes with the traditional mechanical knee versus the microprocessor knee (C-leg) in transfemoral amputees.

Read the detailed description

In older adults, poor circulation in the lower extremities or dysvascular disease can lead to serious health complications. In addition, these individuals also suffer from serious co-morbidities like diabetes and coronary or cerebrovascular disease. Circulatory dysfunction or dysvascular disease is the major cause for amputations in the United States (www.amputee-coalition.orf/fact_sheet/amp_stats_cause.html). Increasing sedentary lifestyles have lead to increased rates of diabetes which has significantly contributed to an increased number of amputations in recent years. The risk of amputation in a diabetic individual is 25 times higher than in the non-diabetic population. The level of amputation that is appropriate for an individual depends on the extent of damage to his/her tissues. Common amputations of the lower extremities in the dysvascular population include the transtibial and transfemoral amputations. The individual having a transtibial or below knee amputation, will be fitted with a prosthetic foot to assist with functional ambulation, while a person with a transfemoral amputation will require both a prosthetic foot and knee for ambulatory purposes. Currently dysvascular amputees are given prostheses based on the goal of returning them to a basic level of function focused primarily on stability. They are considered lower functioning walkers and are expected to use a slow and constant walking speed to ambulate around their homes and are not considered traditional community ambulators. Therefore, they are traditionally given standard mechanical knees which are considered safe, as they provide the ability for only simple single speed house-hold tasks. While this criterion does return the patient to function for basic Activities of Daily Living (ADLs) and walking at a single cadence, it does not empower the patient to counteract the previously existing co-morbidities. Dysvascular amputees tend to be less active predisposing them to a more sedentary lifestyle and exacerbating their risk factors. Their prostheses make them energy inefficient and use more energy for ADLs and functional walking. This causes early onset of fatigue, induces anxiety and fear of falling. Further, they are often depressed, lose motivation and curtail their community interaction. This raises the question if dysvascular amputees are further functionally limited by the prostheses traditionally given to them.

More recently, technology has been used to assist with return to function in the amputee population. Microprocessor (MP) controlled knees are among the technological innovations applied to prostheses to not only return amputees to a basic function, but also with a view to return them to their highest possible function. Over the years, clinical use has shown that traditional knees provide the ability to complete ADLs and basic functions like sit - stand. However, activities like negotiating stairs/steps, walking on uneven ground and self-correction during tripping; functions which reintegrate amputees into unlimited community ambulation and social reintegration require prosthetics which advanced functionality. The Otto Bock C-leg is a MP knee that allows the patient a greater level of control in swing and stance phases of gait. This enables the TF amputee to adjust the requirements of gait during dynamic walking like changing the speed of walking, going up and down stairs and inclines, walking on grass and uneven surfaces and crossing an obstacle. The C-leg has been traditionally given to patients who begin post-amputation rehabilitation at a higher level, but are more expensive than traditionally mechanical knees. In the contrary however, a European study that defined health outcomes in terms of quality-adjusted life year (QALY), indicated that the C-leg showed a QALY gain of €3218 per patient, makes it still financial viable keeping it mind its price tag.. The purpose of this study is to compare the traditional mechanical knee to the microprocessor knee (C-leg) in the dysvascular population. The study will specifically evaluate the potential of microprocessor knees to improve the quality of life in dysvascular transfemoral amputees. This includes identifying if the C-leg can increase the activity level to be classified at a higher level by the Medicare classification from K2 (lower level ambulators) to K3 (more proficient ambulators), along with increasing their social interaction in the community.

02

Conditions studied

  • Transfemoral Amputation
  • Unilateral Traumatic Amputation of Leg at or Above Knee

Browse trials for

Keywords

  • Dysvascular
  • amputation
  • above knee
  • ambulation
03

In context

Amputation, Traumatic

101 studies on the registry are indexed under Amputation, Traumatic; 14 are open to participants now.

This study's enrollment of 10 is below the median of 13 across 68 interventional studies indexed under Amputation, Traumatic.

Browse Amputation, Traumatic studies →

Lead sponsor

Shirley Ryan AbilityLab is the lead sponsor of 177 studies on the registry; 43 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 4 (40%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Males or females with dysvascular transfemoral amputations
  • 6 months or more post prosthetic fitting
  • Homebound or limited community ambulators post amputation
  • Ability to walk > 50m in a 2 min walk test

Exclusion criteria

Exclusion Criteria:

  • Traumatic, cancer or genetic amputation
  • Co-morbidity that completely prevents physical activity
  • Significant skin lesions/ulcers on stump that prevent fitting of prosthesis
  • Cognitive deficits or visual impairments that would impair their ability to give informed consent or to follow simple instructions during experiment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Microprocessor knee then Mechanical knee

    Device: C leg compared to subject's mechanical leg (Otto Bock)

  • Experimental
    Mechanical Knee then Microprocessor knee

    Device: C leg compared to subject's mechanical leg (Otto Bock)

Interventions

  • DeviceC leg compared to subject's mechanical leg (Otto Bock)

    comparison of different prosthetic knees

    Also known as: Otto Bock

  • DeviceC leg compared to subject's mechanical leg (Otto Bock)

    comparison of different prosthetic knees

    Also known as: Otto Bock

06

What researchers measure

Primary outcomes

  1. Change in Community Physical Activity as Measured by GPS

    The difference in social mobility (as seen by GPS) between the 2 devices will be measured.

    Time frame: baseline, 1 month with mechanical knee, 1 month with microprocessor knee

Secondary outcomes

  1. Change in 6 Minute Walk Test From Baseline

    The 6 Minute Walk Test (6MWT) is an endurance test, which measures the distance a subject can walk indoors on a flat, hard surface over a period of 6 minutes, using assistive devices as necessary. The distance covered during the test is measured with a measuring wheel.

    Time frame: After 3 month acclimation period to device

  2. Change in 10 Meter Walk Test Gait Speed From Baseline

    Measure of self selected walking speed by measuring the time it takes an individual to walk 10 meters. The test is performed using a "flying start," patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line.

    Time frame: After 3 month acclimation period to device

  3. Change in Amputee Mobility Predictor Score From Baseline

    The Amputee Mobility Predictor (AMP) instrument is used to asses the functional mobility through a standardized sequence of mobility tests while using the prosthesis. Individual tasks are scored and combined, resulting in a total assessment, which is scored out of 47. The minimum score is zero and maximum score on this scale is 47. Higher scores indicate better mobility.

    Time frame: After 3 month acclimation period to device

  4. Change in Berg Balance Score From Baseline

    The Berg balance scale is used to assess balance during functional activities. It is a performance-based tool, scored between 0 and 56 with higher numbers indicating better balance.

    Time frame: After 3 month acclimation period to device

  5. Change in Timed Up and Go Test Time From Baseline

    The Timed Up and Go (TUG) test is administered to quantify fall risk and functional mobility. TUG is the time taken for the subject to get up from a chair, walk 3 meters, and sit down. The time for the test to be completed is reported in seconds.

    Time frame: After 3 month acclimation period to device

  6. Change in Four Square Step Test Time From Baseline

    The four square step test assesses stepping and change of direction. The subject is asked to walk in a sequence across canes arranged to form four squares. The time to complete the sequence is reported in seconds.

    Time frame: After 3 month acclimation period to device

  7. Change in Modified Falls Efficacy Scale From Baseline

    The Modified Falls Efficacy Scale is used to determine falls and near-falls. It is a self-reported 14-item questionnaire filled out by the subject. Subjects answer questions about how confident they are in safely completing various tasks on a scale from 0 to 10, with 10 indicating greater confidence. The score below is the average item-score for the assessment.

    Time frame: After 3 month acclimation period to device

  8. Change in Community Participation Indicators From Baseline

    The Community Participation Indicators questionnaire will be used to determine community and social participation. It is self-reported outcome measure for community participation. Different questions within the questionnaire correspond to two different aspects of community participation: involvement in life situations and control over participation. These two items are reported first in the table below. The minimum score is 0, and the maximum score is 100. Higher values correspond to higher levels of community participation. These two aspects can be further broken down into percentages of productive activities, social activities, and low-frequency activities performed often enough (the remaining reported values). Each of these percentages has a minimum score of zero and a maximum score of 100, with higher percentages indicating greater satisfaction with the frequency to which the activities are performed.

    Time frame: After 3 month acclimation period to device

  9. Change in Prosthesis Evaluation Questionnaire (PEQ) From Baseline

    The Prosthesis Evaluation Questionnaire (PEQ) will be used to determine prosthesis preference. It is a questionnaire filled out by the subject that is sectioned into validated scales related to usage of the given prosthesis. These validated scales are ambulation, appearance, frustration, perceived response, residual limb health, social burden, sounds, utility, and well being. Items included in these scales are scored between a minimum score of 0 and a maximum score of 100. Reported below are the averages of the validated scales. Thus, the average of each scale has a maximum score of 100 and a minimum score of 0, with a larger value indicating a more positive response.

    Time frame: After 3 month acclimation period to device

07

Results

Posted Sep 6, 2019

Participant flow

Participant flow — Overall Study
MilestoneMicroprocessor Knee Then Mechanical KneeMechanical Knee Then Microprocessor Knee
Started46
Completed45
Not completed01
Withdrew: Lost to follow-up01

Outcome measures

PrimaryChange in Community Physical Activity as Measured by GPS

The difference in social mobility (as seen by GPS) between the 2 devices will be measured.

Time frame:
baseline, 1 month with mechanical knee, 1 month with microprocessor knee
Reported as:
Mean · Steps per day
Change in Community Physical Activity as Measured by GPS
Steps per dayBaselineMechanical KneeMicroprocessor Knee
Change in Community Physical Activity as Measured by GPS1749 ± 20721625 ± 11501257 ± 1164
SecondaryChange in 6 Minute Walk Test From Baseline

The 6 Minute Walk Test (6MWT) is an endurance test, which measures the distance a subject can walk indoors on a flat, hard surface over a period of 6 minutes, using assistive devices as necessary. The distance covered during the test is measured with a measuring wheel.

Time frame:
After 3 month acclimation period to device
Reported as:
Mean · Feet
Change in 6 Minute Walk Test From Baseline
FeetBaselinePost-mechanical KneePost-microprocessor Knee
Change in 6 Minute Walk Test From Baseline434.0 ± 270.3472.2 ± 348.6476.4 ± 361.9
SecondaryChange in 10 Meter Walk Test Gait Speed From Baseline

Measure of self selected walking speed by measuring the time it takes an individual to walk 10 meters. The test is performed using a "flying start," patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line.

Time frame:
After 3 month acclimation period to device
Reported as:
Mean · meters per second
Change in 10 Meter Walk Test Gait Speed From Baseline
meters per secondBaselinePost-mechanical KneePost-microprocessor Knee
Change in 10 Meter Walk Test Gait Speed From Baseline0.483 ± 0.1520.645 ± 0.2730.764 ± 0.282
SecondaryChange in Amputee Mobility Predictor Score From Baseline

The Amputee Mobility Predictor (AMP) instrument is used to asses the functional mobility through a standardized sequence of mobility tests while using the prosthesis. Individual tasks are scored and combined, resulting in a total assessment, which is scored out of 47. The minimum score is zero and maximum score on this scale is 47. Higher scores indicate better mobility.

Time frame:
After 3 month acclimation period to device
Reported as:
Mean · score on a scale
Change in Amputee Mobility Predictor Score From Baseline
score on a scaleBaselinePost-mechanical KneePost-microprocessor Knee
Change in Amputee Mobility Predictor Score From Baseline30 ± 834 ± 636 ± 5
SecondaryChange in Berg Balance Score From Baseline

The Berg balance scale is used to assess balance during functional activities. It is a performance-based tool, scored between 0 and 56 with higher numbers indicating better balance.

Time frame:
After 3 month acclimation period to device
Reported as:
Mean · score on a scale
Change in Berg Balance Score From Baseline
score on a scaleBaselinePost-mechanical KneePost-microprocessor Knee
Change in Berg Balance Score From Baseline35 ± 1039 ± 1444 ± 13
SecondaryChange in Timed Up and Go Test Time From Baseline

The Timed Up and Go (TUG) test is administered to quantify fall risk and functional mobility. TUG is the time taken for the subject to get up from a chair, walk 3 meters, and sit down. The time for the test to be completed is reported in seconds.

Time frame:
After 3 month acclimation period to device
Reported as:
Mean · seconds
Change in Timed Up and Go Test Time From Baseline
secondsBaselinePost-mechanical KneePost-microprocessor Knee
Change in Timed Up and Go Test Time From Baseline29.95 ± 16.1429.91 ± 15.6125.32 ± 14.14
SecondaryChange in Four Square Step Test Time From Baseline

The four square step test assesses stepping and change of direction. The subject is asked to walk in a sequence across canes arranged to form four squares. The time to complete the sequence is reported in seconds.

Time frame:
After 3 month acclimation period to device
Reported as:
Mean · seconds
Change in Four Square Step Test Time From Baseline
secondsBaselinePost-mechanical KneePost-microprocessor Knee
Change in Four Square Step Test Time From Baseline17.96 ± 5.1119.74 ± 11.7216.79 ± 11.17
SecondaryChange in Modified Falls Efficacy Scale From Baseline

The Modified Falls Efficacy Scale is used to determine falls and near-falls. It is a self-reported 14-item questionnaire filled out by the subject. Subjects answer questions about how confident they are in safely completing various tasks on a scale from 0 to 10, with 10 indicating greater confidence. The score below is the average item-score for the assessment.

Time frame:
After 3 month acclimation period to device
Reported as:
Mean · score on a scale
Change in Modified Falls Efficacy Scale From Baseline
score on a scaleBaselinePost-mechanical KneePost-microprocessor Knee
Change in Modified Falls Efficacy Scale From Baseline7.58 ± 1.248.61 ± 1.029.33 ± 0.69
SecondaryChange in Community Participation Indicators From Baseline

The Community Participation Indicators questionnaire will be used to determine community and social participation. It is self-reported outcome measure for community participation. Different questions within the questionnaire correspond to two different aspects of community participation: involvement in life situations and control over participation. These two items are reported first in the table below. The minimum score is 0, and the maximum score is 100. Higher values correspond to higher levels of community participation. These two aspects can be further broken down into percentages of productive activities, social activities, and low-frequency activities performed often enough (the remaining reported values). Each of these percentages has a minimum score of zero and a maximum score of 100, with higher percentages indicating greater satisfaction with the frequency to which the activities are performed.

Time frame:
After 3 month acclimation period to device
Reported as:
Mean · score on a scale
Change in Community Participation Indicators From Baseline
score on a scaleBaselinePost-mechanical KneePost-microprocessor Knee
Involvement in Life Situations49.26 ± 7.2350.16 ± 6.2555.83 ± 18.99
Control over Participation61.68 ± 10.5765.28 ± 10.2474.69 ± 18.67
Percent Social Activities Performed Often Enough67.19 ± 28.6668.62 ± 33.9972.19 ± 34.59
Percent Productive Activities Performed Enough62.96 ± 39.5576.17 ± 26.1872.96 ± 32.55
Percent Low-Frequency Activities Performed Enough57.88 ± 33.5161.43 ± 41.4064.79 ± 35.87
Total Percent of Activities Performed Enough63.91 ± 22.5168.74 ± 27.9769.98 ± 25.06
SecondaryChange in Prosthesis Evaluation Questionnaire (PEQ) From Baseline

The Prosthesis Evaluation Questionnaire (PEQ) will be used to determine prosthesis preference. It is a questionnaire filled out by the subject that is sectioned into validated scales related to usage of the given prosthesis. These validated scales are ambulation, appearance, frustration, perceived response, residual limb health, social burden, sounds, utility, and well being. Items included in these scales are scored between a minimum score of 0 and a maximum score of 100. Reported below are the averages of the validated scales. Thus, the average of each scale has a maximum score of 100 and a minimum score of 0, with a larger value indicating a more positive response.

Time frame:
After 3 month acclimation period to device
Reported as:
Mean · score on a scale
Change in Prosthesis Evaluation Questionnaire (PEQ) From Baseline
score on a scaleBaselinePost-mechanical KneePost-microprocessor Knee
Ambulation58.64 ± 18.7658.28 ± 18.4181.92 ± 18.74
Appearance69.80 ± 19.8668.78 ± 15.2385.91 ± 9.32
Frustration80.8 ± 21.664.1 ± 28.290.2 ± 9.2
Perceived Response83.81 ± 13.4287.39 ± 10.7388.86 ± 13.39
Residual Limb Health82.8 ± 15.179.9 ± 8.985.1 ± 8.8
Social Burdern70.59 ± 23.5276.08 ± 22.7388.72 ± 15.92
Sounds74.20 ± 25.8872.60 ± 30.4993.50 ± 6.62
Utility67.80 ± 18.5967.02 ± 17.9283.92 ± 11.09
Well Being70.05 ± 25.6379.00 ± 18.8185.44 ± 10.75

Adverse events

Collected over Adverse events were monitored/assessed, before and after every data collection session, through study completion, up to 12 months.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Microprocessor Knee0/9 (0%)0/9 (0%)0/9 (0%)
Mechanical Knee0/10 (0%)0/10 (0%)0/10 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Microprocessor Knee Then Mechanical KneeMechanical Knee Then Microprocessor KneeTotal
<=18 years000
Between 18 and 65 years145
>=65 years325
Age, Continuous
Age, Continuous(years)Microprocessor Knee Then Mechanical KneeMechanical Knee Then Microprocessor KneeTotal
Mean67.9 ± 9.760.5 ± 7.563.4 ± 8.8
Sex: Female, Male
Sex: Female, Male(Participants)Microprocessor Knee Then Mechanical KneeMechanical Knee Then Microprocessor KneeTotal
Female336
Male134
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Microprocessor Knee Then Mechanical KneeMechanical Knee Then Microprocessor KneeTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)Microprocessor Knee Then Mechanical KneeMechanical Knee Then Microprocessor KneeTotal
United States4610
08

Study locations

1 site
  • Rehabilitation Institute of Chicago, 345 E Superior St
    Chicago, Illinois 60611, United States
09

References and documents

Publications

  • Theeven P, Hemmen B, Rings F, Meys G, Brink P, Smeets R, Seelen H. Functional added value of microprocessor-controlled knee joints in daily life performance of Medicare Functional Classification Level-2 amputees. J Rehabil Med. 2011 Oct;43(10):906-15. doi: 10.2340/16501977-0861. PubMed 21947182 ↗
  • Jayaraman C, Mummidisetty CK, Albert MV, Lipschutz R, Hoppe-Ludwig S, Mathur G, Jayaraman A. Using a microprocessor knee (C-Leg) with appropriate foot transitioned individuals with dysvascular transfemoral amputations to higher performance levels: a longitudinal randomized clinical trial. J Neuroeng Rehabil. 2021 May 25;18(1):88. doi: 10.1186/s12984-021-00879-3. PubMed 34034753 ↗

Study documents

  • Protocol and statistical analysis plan · Apr 17, 2018

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 6, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01537211
Lead sponsor
Shirley Ryan AbilityLab
Collaborators
Otto Bock Healthcare
Responsible party
Arun Jayaraman, PT, PhD (Director, Rehab Technolgoies and Outcomes Lab, Shirley Ryan AbilityLab) — Principal investigator
First posted
Feb 23, 2012
Start date
Aug 2011
Primary completion
Apr 2019
Completion
Apr 2019
Results posted
Sep 6, 2019
Last update
Sep 6, 2019

Study contacts

Arun Jayaraman, PT PhD
principal investigator · Shirley Ryan AbilityLab

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion